PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE REPLACEMENT BY HIGH-DOSE ASPIRIN OR INTERMITTENT CALF AND THIGH COMPRESSION

被引:157
|
作者
MCKENNA, R [1 ]
GALANTE, J [1 ]
BACHMANN, F [1 ]
WALLACE, DL [1 ]
KAUSHAL, SP [1 ]
MEREDITH, P [1 ]
机构
[1] UNIV CHICAGO,DEPT STAT,CHICAGO,IL 60637
来源
BRITISH MEDICAL JOURNAL | 1980年 / 280卷 / 6213期
关键词
D O I
10.1136/bmj.280.6213.514
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:514 / 517
页数:4
相关论文
共 50 条
  • [41] The Role of Intraoperative Intermittent Pneumatic Compression Devices in Venous Thromboembolism Prophylaxis in Total Hip and Total Knee Arthroplasty
    Tyagi, Vineet
    Tomaszewski, Paul
    Lukasiewicz, Adam
    Theriault, Shahana
    Pelker, Richard
    ORTHOPEDICS, 2018, 41 (01) : E98 - E103
  • [42] Rate of Venous Thromboembolism after Total Hip and Total Knee Replacement in Inpatient Orthopedic Rehabilitation
    Musselmann, Christian
    MEDIZINISCHE KLINIK, 2009, 104 (09) : 694 - 698
  • [43] Discontinued Use of Outpatient Portable Intermittent Pneumatic Compression Devices May Be Safe for Venous Thromboembolism Prophylaxis in Primary Total Knee Arthroplasty Using Low-Dose Aspirin
    Tang, Alex
    Zak, Stephen
    Lygrisse, Katherine
    Slover, James
    Meftah, Morteza
    Lajam, Claudette
    Schwarzkopf, Ran
    Macaulay, William
    JOURNAL OF KNEE SURGERY, 2022, 35 (08) : 909 - 915
  • [44] MODEL SENSITIVITY ANALYSIS OF VENOUS THROMBOEMBOLISM PREVENTION AFTER TOTAL HIP REPLACEMENT
    Vorobiev, P.
    Krasnova, L.
    Shustov, A.
    Bashlakova, E.
    VALUE IN HEALTH, 2012, 15 (07) : A369 - A369
  • [45] Economic Evaluations of New Oral Anticoagulants for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement: A Systematic Review
    James Brockbank
    Sorrel Wolowacz
    PharmacoEconomics, 2017, 35 : 517 - 535
  • [46] Economic Evaluations of New Oral Anticoagulants for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement: A Systematic Review
    Brockbank, James
    Wolowacz, Sorrel
    PHARMACOECONOMICS, 2017, 35 (05) : 517 - 535
  • [47] COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN VERSUS DABIGATRAN AND ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE REPLACEMENT
    Vorobyev, P.
    Krasnova, L.
    Borisenko, O.
    Lukyantseva, D.
    Bashlakova, L.
    VALUE IN HEALTH, 2011, 14 (03) : A41 - A41
  • [48] AVE5026, a new anticoagulant for the prevention of venous thromboembolism in total knee replacement surgery -: TREK:: A dose ranging study
    Lassen, Michael R.
    Dahl, Ola E.
    Mismetti, Patrick
    Destree, Dominique
    BLOOD, 2007, 110 (11) : 98A - 99A
  • [49] COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP AND KNEE REPLACEMENT IN EUROPE
    Monreal, M.
    Ryttberg, L.
    Diamantopoulos, A.
    Lees, M.
    Negrini, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 50 - 51
  • [50] Prevention of Venous Thromboembolism in Total Knee and Hip Replacement (vol 125, pg 2151, 2012)
    Warwick, David
    CIRCULATION, 2012, 126 (10) : E159 - E159